Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
effectively suppresses Src-mediated transformation by inhibiting both CDKs and c-Src
6-diiodophenoxy]ethyl}diethylamine
compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a Ki of 0
ABT-333 (Dasabuvir) is at least 7
Chemical Name: 4-{ethyl[1-(4-methoxyphenyl)propan-2-yl]amino}butan-1-ol
Palbociclib 1150 effectively suppresses Src-mediated transformation byPalbociclib, also known as PD 0332991, is an orally available cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine threonine kinases that
US$ 99.00
US$ 99.00
US$ 55.00
US$ 79.00
US$ 135.00
US$ 45.00
US$ 145.00
US$ 115.00